Nanosphere Financial Statements From 2010 to 2025
| NSHSF Stock | USD 0.01 0.00 0.00% |
Check Nanosphere Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanosphere Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nanosphere financial statements analysis is a perfect complement when working with Nanosphere Health Valuation or Volatility modules.
Nanosphere |
Nanosphere Health Sciences Company Return On Asset Analysis
Nanosphere Health's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Nanosphere Health Return On Asset | -1.37 |
Most of Nanosphere Health's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanosphere Health Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Nanosphere Health Sciences has a Return On Asset of -1.3701. This is 84.34% lower than that of the Healthcare sector and 94.19% lower than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.
Nanosphere Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanosphere Health's current stock value. Our valuation model uses many indicators to compare Nanosphere Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanosphere Health competition to find correlations between indicators driving Nanosphere Health's intrinsic value. More Info.Nanosphere Health Sciences is rated below average in return on asset category among its peers. It is rated below average in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nanosphere Health's earnings, one of the primary drivers of an investment's value.About Nanosphere Health Financial Statements
Nanosphere Health stakeholders use historical fundamental indicators, such as Nanosphere Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nanosphere Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nanosphere Health's assets and liabilities are reflected in the revenues and expenses on Nanosphere Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nanosphere Health Sciences. Please read more on our technical analysis and fundamental analysis pages.
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. The company was incorporated in 2005 and is headquartered in Vancouver, Canada. Nanosphere Health is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Nanosphere Pink Sheet
Nanosphere Health financial ratios help investors to determine whether Nanosphere Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanosphere with respect to the benefits of owning Nanosphere Health security.